Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chr+yseobacterium indologenes bacteremia in an intensive care unit

Japanese Journal of Infectious Diseases

Volumn 64, Issue 6, 2011, Pages 520-524

  Chou, Deng Wei ^a,b   Wu, Shu Ling ^b   Lee, Chao Tai ^a   Tai, Fan Ting ^a   Yu, Wen Liang ^c,d  

^a TAINAN MUNICIPAL HOSPITAL   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFMETAZOLE; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CANDIDA ALBICANS; CATHETER INFECTION; CHRYSEOBACTERIUM INDOLOGENES; CHRYSEOBACTERIUM MENINGOSEPTICUM; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EMPYEMA; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LIVER CIRRHOSIS; MALE; MORTALITY; OUTCOME ASSESSMENT; STAPHYLOCOCCUS AUREUS;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHRYSEOBACTERIUM; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; FLAVOBACTERIACEAE INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 82355161189     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Schreckenberger, P.C., Daneshvar, M.I., Weyant, R.S., et al. (2003): Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative Gram-negative rods. p. 749-779.
2. Murray, P.R., Baron, E.J., Jorgensen, J.H., et al., Manual of Clinical Microbiology. 8th ed. Washington, D.C.
3. Hsueh, P.R., Hsiue, T.R., Wu, J.J., et al. (1996): Flavobacteri-um indologenes bacteremia: clinical and microbiological characteristics. Clin. Infect. Dis., 23, 550-555.
4. Nulens, E., Bussels, B., Bols, A., et al. (2001): Recurrent bactere-mia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin. Microbiol. Infect., 7, 391-393.
5. Green, B.T. and Nolan, P.E. (2001): Cellulitis and bacteraemia due to Chryseobacterium indologenes. J. Infect., 42, 219-220.
6. Lin, J.T., Wang, W.S., Yen, C.C., et al. (2003): Chryseobacteri-um indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease. Scand. J. Infect. Dis., 35, 882-883.
7. Christakis, G.B., Perlorentzou, S.P., Chalkiopoulou, I., et al. (2005): Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor. J. Clin. Microbiol., 43, 2021-2023.
8. Cascio, A., Stassi, G., Costa, G.B., et al. (2005): Chryseobacterium indologenes bacteraemia in a diabetic child. J. Med. Microbiol., 54, 677-680.
9. Ray, P., Sharma, K. and Gautam, V. (2005): Chryseobacterium indologenes bacteremia: a case report. J. Commun. Dis., 37, 259-260.
10. Akay, M., Gunduz, E. and Gulbas, Z. (2006): Catheter-related bacteremia due to Chryseobacterium indologenes in a bone marrow transplant recipient. Bone Marrow Transplant., 37, 435-436.
11. Bayraktar, M.R., Aktas, E., Ersoy, Y., et al. (2007): Postoperative Chryseobacterium indologenes bloodstream infection caused by contamination of distillate water. Infect. Control Hosp. Epidemiol., 28, 368-369.
12. Hsueh, P.R., Teng, L.J., Yang, P.C., et al. (1997): Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur. J. Clin. Microbiol. Infect. Dis., 16, 568-574.
13. Hsueh, P.R., Teng, L.J., Ho, S.W., et al. (1996): Clinical and microbiological characteristics of Flavobacterium indologenes in- fections associated with indwelling devices. J. Clin. Microbiol., 34, 1908-1913.
14. Bone, R.C., Balk, R.A., Cerra, F.B., et al. (1992): Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101, 1644-1655.
15. Roberts, F.J. (1989): Definition of polymicrobial bacteremia. Rev. Infect. Dis., 11, 1029-1030.
16. Clinical and Laboratory Standards Institute (2009): Performance standards for antimicrobial susceptibility testing. 19th information supplement, 29, M100-S19. Clinical and Laboratory Standards Institute. Wayne, Pa.
17. Kirby, J.T., Sader, H.S., Walsh, T.R., et al. (2004): Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J. Clin. Microbiol., 42, 445-448.